#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Prostate cancer Craniopharyngioma Enteritis Cortical dysplasia Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Primary mediastinal large B-cell lymphoma Prolymphocytic leukaemia Chordoma Polycystic liver disease Diffuse large B-cell lymphoma refractory Severe myoclonic epilepsy of infancy Craniocerebral injury Medulloblastoma Acquired C1 inhibitor deficiency Spinal cord injury More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis I – Treatment Basal cell naevus syndrome Medulloblastoma recurrent – Trials in Disease Hereditary motor and sensory neuropathy Chronic granulomatous disease – Basic Information Testicular leiomyosarcoma – Treatment Glomerulonephritis membranous – Life with Disease Brain stem glioma – Trials in Disease Choroid melanoma – Life with Disease Ewing’s sarcoma recurrent – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rezpegaldesleukin Pf-06835375 Emapalumab Palopegteriparatide Gliclazide Ponsegromab Tianeptine Sodium [18F]Mc225 Mitotane Niflumic Acid Vobramitamab Duocarmazine VERTEPORFIN Tumor Necrosis Factor-Alpha Indometacin Progesterone Ph. Eur. Alitretinoin Selexipag Ethanol, Anhydrous Apadamtase Alfa Mitoxantrone Hydrochloride More therapies…

    Learn about Your Condition

    Prostatitis Escherichia coli Lung neoplasm malignant Leiomyosarcoma metastatic Neonatal anoxia Complicated appendicitis Venous thrombosis Lichen sclerosus Sinusitis bacterial Endocarditis Staphylococcal bacteraemia Tertiary adrenal insufficiency Respiratory distress Tendon disorder Bronchitis Metastases to meninges More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Mental Disorders

  • Study on the Effects of Semaglutide on Mood in Patients with Major Depressive Disorder and Overweight or Obesity

    Recruiting

    3 1 1
    Investigated Diseases:
    • Obesity
    • Overweight
    • Depression
    Investigated Drugs:
    • Sodium Chloride
    • Semaglutide
    Denmark

  • Study of semaglutide treatment for adolescents with obesity caused by antipsychotic medications

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Semaglutide
    Denmark

  • Study on the Effects of Cannabidiol and Naltrexone on Alcohol Craving in Patients with Alcohol Dependence

    Recruiting

    2 1
    Investigated Diseases:
    • Alcohol abuse
    • Alcohol use disorder
    Investigated Drugs:
    • Cannabidiol
    Germany

  • Study on How Methylphenidate Works in Adults with ADHD, Comparing Those with and Without Obesity

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Attention deficit hyperactivity disorder
    Investigated Drugs:
    • Methylphenidate Hydrochloride
    France

  • Study on Brain Activity in Treatment-Resistant Depression Using [18F]MC225 for Patients with Depression

    Recruiting

    2 1 1
    Investigated Diseases:
    • Depression
    Investigated Drugs:
    • [18F]Mc225
    Italy

  • Study on Melatonin and Quetiapine for Treating Insomnia in Adolescents with Psychiatric Disorders

    Recruiting

    4 1 1
    Investigated Diseases:
    • Attention deficit hyperactivity disorder
    • Schizoaffective disorder
    • Insomnia
    Investigated Drugs:
    • Melatonin
    • Quetiapine
    Denmark
Previous Page
1 … 7 8 9 10 11 … 40
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!